AGIOS PHARMACEUTICALS, INC. (AGIO) Capital expenditures 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.3MFY2025 · since FY2016: $9.9M → $4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.3M | +156.1% |
| FY2024 | $1.7M | +68.7% |
| FY2023 | $999,000 | -79.5% |
| FY2022 | $4.9M | -15.0% |
| FY2021 | $5.7M | -59.3% |
| FY2020 | $14.1M | +17.3% |
| FY2019 | $12.0M | +72.2% |
| FY2018 | $7.0M | +51.0% |
| FY2017 | $4.6M | -53.3% |
| FY2016 | $9.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice